Latest Articles
Ananda CEO to present at cannabinoid drug summit in Boston By Investing.com - Investing.com Australia
Ananda CEO to present at cannabinoid drug summit in Boston By Investing.com Investing.com Australia
Published: Sept. 16, 2025, 1:17 p.m.
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - PR Newswire
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic PR Newswire
Published: Sept. 16, 2025, 1 p.m.
Camp for diabetic patients praised - BirminghamWorld
Camp for diabetic patients praised BirminghamWorld
Published: Sept. 16, 2025, 10:29 a.m.
Flight Club giving out hundreds of prizes on Birmingham's streets in October - BirminghamWorld
Flight Club giving out hundreds of prizes on Birmingham's streets in October BirminghamWorld
Published: Sept. 16, 2025, 10:23 a.m.
Professor Roslyn Bill selected for the inaugural cohort of the Big if True Science accelerator - BirminghamWorld
Professor Roslyn Bill selected for the inaugural cohort of the Big if True Science accelerator BirminghamWorld
Published: Sept. 16, 2025, 9:37 a.m.
Behind the Build: Lord Mayor of Coventry joins primary school pupils for launch of educational housing experience - BirminghamWorld
Behind the Build: Lord Mayor of Coventry joins primary school pupils for launch of educational housing experience BirminghamWorld
Published: Sept. 16, 2025, 9:30 a.m.
Ananda CEO to present at cannabinoid drug summit in Boston - Investing.com
Ananda CEO to present at cannabinoid drug summit in Boston Investing.com
Published: Sept. 16, 2025, 8:26 a.m.
Ananda CEO to present at cannabinoid drug summit in Boston - Investing.com India
Ananda CEO to present at cannabinoid drug summit in Boston Investing.com India
Published: Sept. 16, 2025, 8:20 a.m.
Trends in Endometriosis Management: A 10-Year US Claims Analysis.
To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations.
Published: Sept. 16, 2025, midnight
How long does combined hormonal therapy suppress AMH levels in women with endometriomas? Results from an exploratory analysis of a clinical trial.
Lower Anti-Müllerian hormone (AMH) levels have been observed in women with ovarian endometriomas (OMA) undergoing combined hormonal contraceptive (CHC) therapy. However, the extent and timing of AMH recovery after CHC …
Published: Sept. 16, 2025, midnight
Link copied to clipboard!